There is still no official diagnosis and classification for Long COVID. A diagnosis is important for many legal aspects such as cost credits or certificates of incapacity for work. Another decisive factor is whether Long COVID will be recognized as an occupational disease. If Long COVID is recognized as an occupational disease, the benefits will be much better than with daily sickness benefit or disability insurance. For an overview of legal issues, we refer to the association Verband Covid Langzeitfolgen (in German).
Long COVID does not only concern medicine and science, but affects all spheres of society. Here you can find a brief overview of the current situation and open questions in related fields.
The topic of Long COVID is present with various approaches in Swiss politics. The National Council's Health Commission (SGK-N) has mandated the Federal Council to provide sufficient financial resources for research into Long COVID. A corresponding motion was accepted in mid-June 2021.
The Council of States, in turn, has approved the postulate "Garantir aux personnes atteintes du "Covid long" un traitement et une réadaptation appropriés" ("Ensuring appropriate treatment and rehabilitation for people with Long COVID”. The Federal Council must now set out in a report how the health care of patients with long-term consequences of a COVID-19 infection is and how the treatment can be financed.
The impact on society of Long COVID can only be vaguely estimated today. This is due to the lack of clarity of the situation and the definition of the data: depending on the study and the population examined, the proportion of those who develop long-term symptoms after infection with SARS-CoV-2 varies between 4 % and more than 50%. A study in Zurich showed that around a quarter of patients had not fully recovered six months after infection, of which around 10% were still severely limited in their daily lives.
It is clear that the greater the number of people affected, the more noticeable the effects are at all levels of society: those affected are absent from families, clubs and the workplace. There is the risk that they will feel misunderstood and defeated. They need care, new forms of therapy and support to get back to their daily lives. This presents a challenge for them, for their environment and for society as a whole.
There is little scientific knowledge about the Long COVID. Altea has therefore the goal of encouraging exchange between those concerned, scientists and therapists in order to acquire knowledge about this new syndrome. In our Vademecum you will find constantly updated information, verified by affected people, scientists and therapists. In the Directory, we list the consultations and specialized therapies.